George F Tidmarsh's Net Worth

$492 Million

Estimate Recalculated Feb 23, 2024 06:08AM EST

Who is George F Tidmarsh?

George F Tidmarsh has an estimated net worth of $492 Million. This is based on reported shares across multiple companies, which include Odonate Therapeutics, Inc., REVELATION BIOSCIENCES, INC., ANAVEX LIFE SCIENCES CORP., SPECTRUM PHARMACEUTICALS INC, THRESHOLD PHARMACEUTICALS INC, and LA JOLLA PHARMACEUTICAL CO.

SEC CIK

George F Tidmarsh's CIK is 0001287235

Past Insider Trading and Trends

2019 was George F Tidmarsh's most active year for acquiring shares with 23 total transactions. George F Tidmarsh's most active month to acquire stocks was the month of February. 2023 was George F Tidmarsh's most active year for disposing of shares, totalling 7 transactions. George F Tidmarsh's most active month to dispose stocks was the month of August. 2014 saw George F Tidmarsh paying a total of $496,050.00 for 234,000 shares, this is the most they've acquired in one year. In 2023 George F Tidmarsh cashed out on 67,502 shares for a total of $42,761.16, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Odonate Therapeutics, Inc. (ODTC) Snapshot price: $3210

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
151.29K
151.29K
Sep 19
Form 4
0
0
Dec 31
Form 4
0
0
Jan 2
Form 3
0
0
No matching records found

REVELATION BIOSCIENCES, INC. (REVB) Snapshot price: $2.55

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-27.77K
$0.52
-$14,438.14
0
Dec 8
Form 4
-6.23%
-1.84K
$0.65
-$1,199.43
27.77K
Oct 16
Form 4
-20.65%
-10.96K
$0.66
-$7,242.58
42.1K
Oct 16
Form 4
-3.28%
-1.43K
$0.69
-$986.01
42.1K
Sep 28
Form 4
-39.32%
-25.50K
$0.74
-$18,895.00
39.35K
Sep 14 - Sep 18
Form 4
+385.83%
51.5K
$1.16
$59,740.00
64.85K
Apr 17 - Apr 18
Form 4
0
0
Apr 14
Form 4
+4.47%
20K
$1.60
$32,000.00
467.16K
Feb 25
Form 4
+7.45%
31K
$2.55
$79,139.00
447.16K
Feb 8 - Feb 9
Form 4/A
+2.75%
52K
$2.51
$132,936.07
1.94M
Feb 4 - Feb 7
Form 4
+3.39%
50K
$2.56
$128,036.07
1.52M
Feb 4 - Feb 7
Form 3
0
0
No matching records found

ANAVEX LIFE SCIENCES CORP. (AVXL) Snapshot price: $5.635

Executive Director

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
8K
$1.25
$10,000.00
8K
Feb 9
Form 3
0
0
No matching records found

SPECTRUM PHARMACEUTICALS INC No price found

CSO and Head R&D Operations

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+100.00%
20K
40K
Jan 3
Form 4
+33.33%
5K
$4.03
$20,150.00
20K
Aug 13
Form 4
15K
15K
Jul 15
Form 3
0
0
No matching records found

THRESHOLD PHARMACEUTICALS INC (MTEM) Snapshot price: $3.7

Founder and President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.40%
4K
$5.95
$23,787.05
992.22K
Mar 10 - Mar 11
Form 3
0
0
No matching records found